Lakhmir S Chawla

This inventor holds 21 USPTO granted patents and 24 published patent applications and 5 EPO patents, primarily in Biomarker Diagnostics. Top assignees: The George Washington University, La Jolla Pharma, LLC, Astute Medical, Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakhmir S Chawla. Retrieved from https://idiyas.com/inventor/lakhmir-s-chawla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 24)

% Patents Active = 100.0

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 88(Granted Patents)

Location History:

McLean, VA (US) (2015 - 2023)
San Diego, CA (US) (2019 - 2023)

Company Filing History:

17 out of 283

The George Washington University

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Blood Biomarkers

Appendicitis

Respiratory Infections

Renal Injury

Angiotensin II

Hypotension

Diagnostics Methods

Prognosis

ACE Inhibitor

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12215386 - Blood biomarkers for appendicitis and diagnostics methods using biomarkers (2025-02-04),

2. 12203941 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure (2025-01-21),

3. 11629383 - Blood biomarkers for respiratory infections (2023-04-18),

4. 11583568 - Methods for administering angiotensin II (2023-02-21),

5. 11559559 - Angiotensin II alone or in combination for the treatment of hypotension (2023-01-24),

6. 11371096 - Blood biomarkers for appendicitis and diagnostics methods using biomarkers (2022-06-28),

7. 11219662 - Methods for treating hypotension in a patient that has received an ACE inhibitor by administering angiotensin II (2022-01-11),

8. 11096983 - Angiotensin II alone or in combination for the treatment of hypotension (2021-08-24),

9. 11066706 - Blood biomarkers for appendicitis and diagnostics methods using biomarkers (2021-07-20),

10. 10851418 - Blood biomarkers for respiratory infections (2020-12-01),

11. 10765722 - Angiotensin II alone or in combination for the treatment of hypotension (2020-09-08),

12. 10548943 - Method of treating low blood pressure (2020-02-04),

13. 10500247 - Method of treating low blood pressure (2019-12-10),

14. 10493124 - Angiotensin II alone or in combination for the treatment of hypotension (2019-12-03),

15. 10406201 - Methods for administering angiotensin II (2019-09-10),

Certainly! Here is an article about inventor Lakhmir S Chawla:

Title: Pioneering Innovations: The Legacy of Lakhmir S Chawla

Introduction:

In the realm of inventions, few trailblazers shine as brightly as Lakhmir S Chawla, a visionary inventor based in McLean, VA. With a staggering 19 patents to his name, Chawla's innovative spirit and dedication have propelled him to the forefront of technological advancement.

Latest Patents:

Chawla's latest patents exemplify his commitment to advancing healthcare technologies. One notable invention involves the use of blood biomarkers for diagnosing and treating lower respiratory infections. By detecting RNA expression levels of specific biomarkers, this method offers a groundbreaking approach to identifying and managing respiratory illnesses. Another patent focuses on the therapeutic use of angiotensin II for treating hypotension, particularly catecholamine-resistant hypotension.

Career Highlights:

Throughout his illustrious career, Chawla has made significant contributions to institutions such as The George Washington University and La Jolla Pharma, LLC. His expertise and innovative prowess have played a pivotal role in driving advancements in the field of healthcare technology, earning him a reputation as a true pioneer in his field.

Collaborations:

In his journey towards innovation, Chawla has collaborated with esteemed professionals such as Timothy A McCaffrey and George Tidmarsh. These partnerships have not only enriched his work but have also led to the development of groundbreaking inventions that have the potential to transform the healthcare landscape.

Conclusion:

In conclusion, Lakhmir S Chawla's remarkable journey as an inventor is a testament to his unwavering dedication to pushing the boundaries of technology. His prolific inventions and collaborative spirit have cemented his status as a trailblazer in the world of innovations, inspiring future generations to continue exploring the endless possibilities of technological advancement.

Profile summary based on public USPTO records.